Nitric Oxide

Nitric Oxide

SCHEMBL951135

S.[N]=O

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GUCY1A1GUCY1A2GUCY1B1GUCY1B2

The experimentally established mechanism targets of Nitric Oxide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Nitric Oxide SCHEMBL7560 0.87
Nitric Oxide SCHEMBL3993955 0.87
Nitric Oxide SCHEMBL37670 0.75
Nitric Oxide SCHEMBL5104249 0.75
Nitric Oxide SCHEMBL7184108 0.75
Nitric Oxide SCHEMBL2888647 0.75
Nitric Oxide SCHEMBL306589 0.75
Nitric Oxide SCHEMBL2731176 0.75
Nitric Oxide SCHEMBL3636459 0.75
Nitric Oxide SCHEMBL2890900 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-8092203-A None JP disclosed
US-12037307-B2 2024-07-16 US disclosed
EP-4388876-A2 FUNGICIDAL NITROANILINO SUBSTITUTED PYRAZOLES FMC Corporation (US) 2024-06-26 EP disclosed
CN-112969688-B Fungicidal nitroaniline-substituted pyrazoles FMC公司 2024-06-04 CN disclosed
EP-3847160-B1 FUNGICIDAL NITROANILINO SUBSTITUTED PYRAZOLES FMC CORP (US) 2024-05-08 EP disclosed
US-20230227400-A1 HIGH PURITY 2-NAPHTHYLACETONITRILE AND METHOD FOR PRODUCING SAME API CORPORATION (JP) 2023-07-20 US disclosed
US-20230148599-A1 FUNGICIDAL MIXTURES CONTAINING PYRAZOLE DERIVATIVES FMC CORPORATION 2023-05-18 US disclosed
US-11643386-B2 High purity 2-naphthylacetonitrile and method for producing same API CORPORATION (JP) 2023-05-09 US disclosed
EP-4118072-A1 FUNGICIDAL MIXTURES CONTAINING PYRAZOLE DERIVATIVES FMC CORPORATION (US) 2023-01-18 EP disclosed
CN-115605461-A Fungicidal mixtures containing pyrazole derivatives FMC公司(US) 2023-01-13 CN disclosed
EP-1536784-A1 HETERO BIARYL DERIVATIVES AS MATRIX METALLOPROTEINASE INHIBITORS WARNER-LAMBERT COMPANY LLC (US) 2005-06-08 EP disclosed
EP-1506175-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDGF RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2005-02-16 EP disclosed
US-20040082639-A1 N-substituted tricyclic 3-aminopyrazoles as inhibitors for the treatment of cell proliferative disorders JANSSEN PHARMACEUTICA, N.V. (BE) 2004-04-29 US disclosed
US-20040048863-A1 Hetero biaryl derivatives as matrix metalloproteinase inhibitors WARNER-LAMBERT COMPANY LLC 2004-03-11 US disclosed
WO-2004014366-A1 HETERO BIARYL DERIVATIVES AS MATRIX METALLOPROTEINASE INHIBITORS WARNER-LAMBERT COMPANY LLC (US) 2004-02-19 WO disclosed
WO-2003097609-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDFG RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2003-11-27 WO disclosed
US-6509361-B1 Inhibit the activity of p38 MAP kinase. Also contemplated by the invention are processes for the preparation of the contemplated compounds and for the use of a contemplated compound in treating a mammalian host having a p38 kinase or PHARMACIA CORPORATION 2003-01-21 US disclosed
CN-2503363-Y Spray thrower WEI JINGCAI (CN) 2002-07-31 CN disclosed
JP-H0892203-A BATA-KETOTHIOAMIDE DERIVATIVE AND ITS PRODUCTION AGENCY OF IND SCIENCE & TECHNOL 1996-04-09 JP disclosed
US-5167834-A PROCESS FOR TREATING NITRITE-AND SULFIDE-CONTAINING WATER TO REDUCE NITROGEN OXIDE AND HYDROGEN SULFIDE EMISSIONS THEREFROM UNION OIL COMPANY OF CALIFORNIA (US) 1992-12-01 US disclosed